Cara Care Raises $7M Series A Led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Asabys Partners
Company will use funds to scale its Cara Care digital therapeutic for life-interrupting digestive diseases.
Company will use funds to scale its Cara Care digital therapeutic for life-interrupting digestive diseases.
Under this call EU-OPENSCREEN-DRIVE offers funding to enable transnational access to chemical proteomics and compound disposition study facilities. A total of 6 projects will be selected in two separate calls (scheduled May 2019…
Under this call 12 EU-OPENSCREEN-DRIVE partner institutions will each offer one predefined screening technology to external users. The user will provide the biological question and the related assay matching the offered techniques. The offered…
Keys to Japan is an European Commission-funded initiative, managed by the EU-Japan Centre. If you are considering marketing a product or service in Japan and you are an SME from an EU Member-State or COSME Third Country, under Keys to Japan, you can…
The Emerging Technologies Competition is the Royal Society of Chemistry’s annual initiative for early stage companies and academic entrepreneurs who want to commercialise their technologies to make a global impact.
Die Berliner Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), ein Spezialist für isotopentechnische Anwendungen in Medizin, Wissenschaft und Industrie, wird mit Wirkung zum 24. Juni 2019 in den SDax aufgenommen. Diese…
BIH scientists have been able to observe receptors transmitting signals inside the cell
The body’s own signaling molecules, and many drugs, often exert their effect via cell surface receptors. These receptors poke through the cell membrane,…
The “Future Award Healthcare Industry” is awarded annually by the Club of Healthcare Industry (cdgw). The award consists of two parts: a reward of 5,000 euros and a publication of the award winner in the professional magazine “kma” (Thieme group).…
On June 1, 2019, Professor Christof von Kalle will become a tenured professor of clinical translational sciences at the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin. The cancer expert will head the joint BIH and Charité…
ProBioGen AG, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, today announced the closing of a services and license agreement with Abcuro, Inc. Pursuing a new generation of immune modulatory…